Status:
COMPLETED
Cardiovascular Risk Stratification of Ambulatory Patients in Primary Prevention
Lead Sponsor:
AstraZeneca
Conditions:
Cardiovascular Primary Prevention
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general prac...
Detailed Description
This is an observational, cross-sectional, national multicenter study, trying to obtain local data about the global cardiovascular risk profile of patients attending ambulatory offices of general prac...
Eligibility Criteria
Inclusion
- Patients older than 18 years of age, who give their written consent to take part.
- Patients without known vascular disease (primary prevention) under follow-up by the investigator, whose medical records have been initiated during the last 3 years.
- Patients who have completed their baseline CV risk assessment Lipid lowering treatment naive patients at the time of the stratification.
Exclusion
- Incomplete or missing medical record data.
- Subjects with prior cardiovascular disease (peripheral vascular disease, coronary or cerebrovascular disease) symptomatic or asymptomatic.
- Subjects with terminal status disease or short life expectancy.
- Hypothyroidism without proper control.
- Pregnancy.
- Medical records compiled within a period longer than 3 years to the date of inclusion.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2014
Estimated Enrollment :
516 Patients enrolled
Trial Details
Trial ID
NCT01889030
Start Date
July 1 2013
End Date
June 1 2014
Last Update
July 24 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Buenos Aires, Argentina